期刊文献+

先天性心脏病住院患者医疗指标及费用构成分析 被引量:6

Medical Indicators and Expense Composition of Inpatients with Congenital Heart Diseases
暂未订购
导出
摘要 目的分析先天性心脏病患者的医疗质量和医疗费用及费用构成情况,为医院合理救治、卫生主管部门制定和调整救助政策提供参考。方法计算机提取某三级甲等医院2009/2011年收治先天性心脏病患者病种、医疗数质量指标和经济数据,运用EXCEL2007进行数据统计分析。结果①经临床路径治疗的先天性心脏病患者,治愈率81.69%,治愈好转率92.65%;②人均住院日13.49天,治愈者人均住院日14.32天;③人均医疗费用21 993元,其中治疗、手术费占费用构成的65.76%;④药品费用呈现递减趋势,治疗费呈现递增趋势。结论医疗指标在标准质控范围,医疗费用结构渐趋合理;引入介入治疗技术,实施临床路径治疗模式,有助于提高治愈率、缩短人均住院日、降低医疗费用;扩展医疗救助病种范围,有助于提高治疗覆盖率。 Objective To analyze the medical quality,medical expenses and expense composition of the inpatients with congenital heart diseases,and provide reference for proper treatment and aid policy development and adjustment of the health management department.Methods The types of diseases,medical quality index and economic data of inpatients with congenital heart disease from 2009 to 2011 in a tertiary-grade A class hospital were extracted and analysed by EXCEL2007.Results The cure rate of the patients treated according the clinical pathway was 81.69%,and the cure or improvement rate was 92.65%.The average length of stay was 13.49 days,and for cured paeints 14.32 days.The average medical expense was 21 993 yuan,among which 65.76% was therapy and surgery expense.The drug expense was decreased and the therapeutic expense was increased.Conclusion The medical indicators are in the standard quality control scope and the expense structure is tuning reasonable.Interventional therapy and carrying out clinical pathway treatment can effectively increase the cure rate and decrease the average length of stay and expense.Extending the relief scope helps to increase the treatment coverage rate.
出处 《华南国防医学杂志》 CAS 2012年第5期499-501,515,共4页 Military Medical Journal of South China
基金 解放军总后勤部2010年度计划课题(10WQZ15)
关键词 先天性心脏病 医疗 费用 Congenital heart disease Medicine Expense
  • 相关文献

参考文献9

二级参考文献78

共引文献53

同被引文献54

  • 1丁芳宝,梅举,邹良建,赵枫,张宝仁.非体外循环下有搏动性双向Glenn手术治疗复杂先天性心脏病[J].中国胸心血管外科临床杂志,2005,12(1):46-47. 被引量:18
  • 2傅丽娟,顾晓蓉,管咏梅,何萍萍,王顺民,徐志伟,徐莉华.临床路径在小儿先天性心脏病治疗中的应用和评价[J].解放军护理杂志,2006,23(11):23-24. 被引量:5
  • 3Van der Linde D,Konings EE,Slager MA,et al.Birth prevalence of congenital heart disease worldwide:a systematic review and meta-analysis[J].J Am Coll Cardiol,2011,58(21):2241-2247.
  • 4Ishikawa T,Iwashima S,Ohishi A,et al.Prevalence of congenital heart disease assessed by echocardiography in 2067 consecutive newborns[J].Acta Paediatr,2011,100(8):e55-e60.
  • 5Zou M. Factors affecting the prognosis of children refractory pneumonia risk and prevention analysis [J]. Mod Chin Doc, 2013,51(17) :44-47.
  • 6白明辉,亢杨,王兴.先天性心脏病相关危险因素前瞻性调查和监测网络建设的必要性[J].中国保健营养,2013,8(11):528-529.
  • 7Lee K, Khoshnood B, Chen L, et al. Infantm ortality from congeni- tal malformations in the United States, 1997-2009[J].Obstet Gy- necol,2010,16(98) :620-662.
  • 8Rotter T,Kinsman L,James E,et al.The effects of clinical pathways on professional practice,patient outcomes,length of stay,and hospital costs:Cochrane systematic review and meta-analysis[J].Eval Health Prof,2012,35(1):3.
  • 9Lohfert C,Kalmár P.Clinical pathways:experiences,expectations,and perspectives[J].Der Internist,2006,47(7):676,678.
  • 10Wang S,Yu H,Liu J,et al.Exploring the methodology and application of clinicalpathway in evidence-based Chinese medicine[J].Front Med,2011,5(2):157.

引证文献6

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部